(Q34111749)

31 July 2017

title

Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus (English)

1 reference

31 July 2017

1 reference

Bundibugyo ebolavirus

object named as

Bundibugyo ebolavirus

1 reference

4

Pierre E Rollin

1 reference

31 July 2017

Christina F Spiropoulou

series ordinal

5

object named as

Christina F Spiropoulou

1 reference

31 July 2017

Manisha Gupta

1

1 reference

31 July 2017

Adam MacNeil

series ordinal

2

1 reference

31 July 2017

Zachary D Reed

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

23 December 2011

1 reference

31 July 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

31 July 2017

volume

423

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

119-124

1 reference

The balance between IL-1 and IL-1Ra in disease

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

Inflammatory responses in Ebola virus-infected patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

Nitric oxide and infectious diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

7 January 2021

Ebola haemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

Reduced virus replication, proinflammatory cytokine production, and delayed macrophage cell death in human PBMCs infected with the newly discovered Bundibugyo ebolavirus relative to Zaire ebolavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

Cytokine and chemokine expression in humans infected with Sudan Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

Human asymptomatic Ebola infection and strong inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

Interleukin-10 but not Transforming Growth Factor beta inhibits murine activated macrophages Paracoccidioides brasiliensis killing: effect on H2O2 and NO production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

Strategies for use of IL-10 or its antagonists in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.11.027

10.1016/J.VIROL.2011.11.027

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference